SYSTEMS, DEVICES, AND METHODS EMPLOYING THERAPEUTIC ULTRASOUND OF LIVING TISSUES

• US 20070249969A1
• Filed: 04/20/2007
• Published: 10/25/2007
• Est. Priority Date: 04/20/2006
• Status: Abandoned Application

• Current Assignee: Donald Shields
• Original Assignee: Donald Shields
• Inventors: Shields, Donald
• Application Number:
  US11/738,423
• Publication Number:
  US 20070249969A1
• Time in Patent Office: Days
• US Class Current: 601/2
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

Systems, devices, and methods for delivering ultrasonic treatment to a subject. An ultrasound therapy device includes a waveform generator, one or more transducers, one or more sensors, and a controller. In some embodiments, the waveform generator is configured to generate a first driving signal having at least a first waveform segment and a second waveform segment different from the first waveform segment.

Claims

1. An ultrasound therapy device for delivering ultrasonic treatment to a biological entity, comprising:

a waveform generator configured to generate a first driving signal, the first driving signal comprising at least a first waveform segment and a second waveform segment different from the first waveform segment;

one or more transducers electrically, wirelessly, or inductively coupled to the waveform generator, the one or more transducers configured to receive the first driving signal and to generate a first ultrasonic signal based in part on the first driving signal;

one or more sensors operable to determine at least one physiological characteristic of the biological entity; and

a controller electrically coupled the waveform generator and the one or more sensors, the controller configured to perform a comparison of the determined at least one physiological characteristic of the biological entity to stored reference data, and to generate a response based in part on the comparison.

2. The device of claim 1, wherein the first waveform segment has at least one of an intensity, a frequency, a pulse intensity, a pulse duration, a pulse frequency, a pulse ratio, or a pulse repetition rate different from the second waveform segment.

3. The device of claim 1, wherein at least one of the first waveform or the second waveform segments comprises a continuous waveform.

4. The device of claim 1, wherein the first and the second waveform segments are each independently selected from one or more single-sine waveforms, multi-sine waveforms, frequency-swept sine waveforms, step waveforms, pulse waveforms, square waveforms, triangular waveforms, saw-tooth waveforms, arbitrary waveforms, generated waveforms, chirp waveforms, non-sinusoidal waveforms, and ramp waveforms, or combinations thereof.

5. The device of claim 1, wherein the first driving signal comprises a repeating signal comprising one or more waveforms selected from single-sine waveforms, multi-sine waveforms, frequency-swept sine waveforms, step waveforms, pulse waveforms, square waveforms, triangular waveforms, saw-tooth waveforms, arbitrary waveforms, generated waveforms, chirp waveforms, non-sinusoidal waveforms, and ramp waveforms, single-frequency formed waves, multi- frequency formed waves, or combinations thereof.

6. The device of claim 1, wherein the generated first ultrasonic signal compromise at least one of a continuous or a pulsed ultrasonic treatment wave, or combinations thereof.

7. The device of claim 1, wherein an intensity of the first ultrasonic signal ranges from about 0.02 W/cm² to about 3 W/cm².

8. The device of claim 1, wherein an intensity of the first ultrasonic signal ranges from about 0.02 W/cm² to about 1.5 W/cm².

9. The device of claim 1, wherein an intensity of the first ultrasonic signal ranges from about 0.4 W/cm² to about 1.5 W/cm².

10. The device of claim 1, wherein a pulse ratio of the first ultrasonic signal ranges from about to about 1:

1 to about 1;

20.

11. The device of claim 1, wherein a frequency of the first ultrasonic signal ranges from about 0.05 MHz to about 3 MHz.

12. The device of claim 1, wherein a pulse repetition rate of the first ultrasonic signal ranges from about 50 KHz to about 10,000 Hz.

13. The device of claim 1, wherein a pulse duration of the first ultrasonic signal ranges from about 10 μ

s to about 2,500 μ

s.

14. The device of claim 1 wherein the first ultrasonic signal comprises a pulse duration ranging from about 10 μ

s to about 2,500 μ

s, a pulse ratio ranging from about 1;

1 to about 1;

8, a pulse repetition rate ranging from about 50 Hz to about 10,000 Hz, and a pulse intensity ranging about 0.02 W/cm² to about 3 W/cm².

15. The device of claim 1, wherein the first ultrasonic signal comprises a pulse repetition rate ranging from about 500 Hz to about 2,500 Hz, and a pulse duration ranging from about 100 μ

s to about 500 μ

s.

16. The device of claim 1, wherein the waveform generator is further configured to cycle through the at least first and the second waveform segments for a limited treatment time.

17. The device of claim 1, wherein at least one of the one or more sensors is operable to generate a response based in part on whether the one or more transducers are physically contacting a treatment site on the biological subject.

18. The device of claim 1, wherein the one or more transducers take the form of a transducer array.

19. The device of claim 1, wherein the waveform generator is configured to generate the first driving signal based in part on a user input.

20. The device of claim 19, wherein the user input comprises at least one of a continuous output, a pulsed output, an intensity, a frequency, a pulse ratio, a pulse intensity, a pulse duration, a pulse frequency, a pulse repetition rate, a treatment type, a treatment time, a treatment time increase or decrease, a treatment interval rate, a lesion depth, a degree of tissue injury, and a tissue type, or combinations thereof.

21. The device of claim 20, wherein the degree of tissue injury is selected from an acute injury, a sub-acute injury, a chronic injury;

and the tissue type is selected from bone, cartilage, muscle, tendon, ligament, and stem cells, or combinations thereof.

22. The device of claim 1, wherein the generated response includes at least one of a response signal, a comparison plot, a treatment code, a diagnostic code, a test code, an alarm, a change to a treatment parameter, and a response signal operable to terminate the first driving signal.

23. The device of claim 1, wherein the controller is further configured to track at least one treatment parameter selected from a treatment type, a treatment time, a treatment duration, a lesion depth, a degree of tissue injury, a tissue type, an intensity, a frequency, a pulse frequency, a pulse ratio, a pulse intensity, a pulse duration, a pulse frequency, a pulse repetition rate, a continuous waveform frequency, and a continuous waveform intensity.

24. The device of claim 1, wherein the least one physiological characteristic is selected from an impedance, a temperature, a density, and/or a fat content of the biological entity.

25. The device of claim 1, wherein the stored reference data comprises at least one of characteristic physiological data, characteristic impedance data, characteristic temperature data, characteristic density data, and characteristic fat content data.

26. The device of claim 1, wherein the generated response comprises an instruction to the waveform generator to control at least one of an intensity, a frequency, a pulse frequency, a pulse ratio, a pulse intensity, a pulse duration, a pulse frequency, a pulse repetition rate, a continuous waveform frequency, and a continuous waveform intensity of the first driving signal.

27. An ultrasound therapy system for delivering ultrasonic treatment to a biological entity, comprising:

an inductive power supply including a primary winding operable to produce a varying magnetic field; and

an ultrasound delivery device, the ultrasound delivery device comprising a waveform generator configured to generate a first driving signal, the first driving signal comprising at least a first waveform segment and a second waveform segment, the second waveform segment different from the first;

a secondary winding electrically coupled to the waveform generator and operable for providing a potential to the waveform generator in response to a varying electromagnetic field applied to the secondary winding; and

one or more transducers electrically coupled to the waveform generator, the one or more transducers configured to receive the first driving signal and to generate a first ultrasonic signal based in part on the first driving signal.

28. The system of claim 27, wherein the ultrasound delivery device is physically distinct from the inductive power supply.

29. The system of claim 27, wherein the inductive power supply is operable to provide at least one of an alternating current or a pulsed direct current to the primary winding.

30. The system of claim 27, wherein the ultrasound therapy device includes a rechargeable power source electrically coupled to the waveform generator, and electrically coupled in parallel with the secondary winding to receive a charge thereby.

31. The system of claim 27, wherein the rechargeable power source sinks and sources voltage to maintain a steady state operation of the ultrasound therapy device.

32. The ultrasound therapy device of claim 31, the rechargeable power source comprises at least one of a button cell, a chemical battery cell, a fuel cell, a secondary cell, a lithium ion cell, a nickel metal hydride cell, a super-capacitor, a thin film secondary cell, an ultra-capacitor, and a zinc air cell.

33. The system of claim 27, wherein the inductive power supply is operable to manage a duty cycle associated with emitting a therapeutically effective amount of ultrasonic energy from the ultrasound delivery device.

34. The ultrasound therapy device of claim 27, further comprising:

one or more sensors operable to determine at least one physiological characteristic of the biological entity; and

a controller electrically coupled the waveform generator and the one or more sensors, the controller configured to perform a comparison of the determined at least one physiological characteristic of the biological entity to stored reference data, and to generate a response based in part on the comparison.

35. A method of treating at least one condition associated with injured tissue in a subject, comprising:

contacting a location on a biological interface of the subject with an ultrasound delivery device comprising one or more ultrasound transducers, the at least the one or more ultrasound transducers operable for providing an ultrasonic signal comprising at least a first waveform segment and a second waveform segment;

the first waveform segment having at least one of an intensity, a frequency, a pulse intensity, a pulse duration, a pulse ratio, or a pulse repetition rate different from the second segment; and

applying a sufficient amount of current to emit a therapeutically effective amount of ultrasonic energy from the ultrasound delivery device.

36. The method of claim 35, wherein applying a sufficient amount of current comprises applying a sufficient amount of current to emit a therapeutically effective amount of ultrasonic energy for at least one interval in a 24 hour period, the interval ranging from about 5 minutes to about 60 minutes.

37. The method of claim 35, wherein applying a sufficient amount of current comprises applying a sufficient amount current to emit a therapeutically effective amount of ultrasonic energy for at least one to three intervals in a 24 hour period, each interval independently ranging from about 5 minutes to about 60 minutes.

38. The method of claim 37, wherein each interval independently ranges from about 20 minutes to about 45 minutes.

39. The method of claim 35, further comprising:

providing at least one control parameter, the at least one control parameter selected from a tissue type, a treatment area, a lesion depth, a degree of injury, a treatment type, a duration type, and one or more waveform characteristics.

40. The method of claim 39, wherein the treatment type is selected from continuous or pulsed, and the one or more waveform characteristics are selected from an intensity, a frequency, a pulse intensity, a pulse duration, a pulse ratio, and a pulse repetition rate.

41. The method of claim 39, wherein the degree of injury is selected from an acute injury, a sub-acute injury, and a chronic injury.

42. The method of claim 39, wherein the tissue type is selected from bone, cartilage, muscle, tendon, ligament, and stem cells, or combinations thereof.

43. The method of claim 35, further comprising:

providing stem cell therapy before, during, and/or after emitting the therapeutically effective amount of ultrasonic energy.

44. The method of claim 43, wherein providing stem cell therapy includes providing stem cell implantation, stem cell transplantation, or stem cell delivery to the injured tissue, or combinations thereof.

45. The method of claim 44, wherein providing stem cell therapy further includes administering one or more bioactive agents to the injured tissue.

46. The method of claim 45, wherein the one or more bioactive agents are selected from TGF-beta, IGF-1, BMP-2, CDMP-2, FGF-1, bone morphogenic proteins, cartilage-derived morphogenic proteins, tissue growth factors, transforming growth factors, insulin-like growth factors, fibroblast growth factors and hyaluronans, or combinations thereof.

47. The method of claim 35, further comprising:

treating the injured tissue with one or more bioactive agents before, during, and/or after providing stem cell therapy to the injured tissue, and

treating the injured tissue with one or more bioactive agents before, during, and/or after emitting the therapeutically effective amount of ultrasonic energy.

48. The method of claim 35, further comprising:

electronically modulating at least one of an intensity, a frequency, a pulse intensity, a pulse duration, a pulse frequency, a pulse ratio, or a pulse repetition rate of the ultrasonic signal.

49. An article of manufacture for delivering ultrasound therapy, comprising:

an ultrasound therapy device for delivering ultrasonic treatment to a biological entity, comprising;

a waveform generator configured to generate a first driving signal, the first driving signal comprising at least a first waveform segment and a second waveform segment different from the first waveform segment;

one or more transducers electrically coupled to the waveform generator, the one or more transducers configured to receive the first driving signal and to generate a first ultrasonic signal based in part on the first driving signal;

one or more sensors operable to determine at least one physiological characteristic of the biological entity;

a controller electrically coupled the waveform generator and the one or more sensors, the controller configured to perform a comparison of the determined at least one physiological characteristic of the biological entity to stored reference data, and to generate a response based in part on the comparison; and

a package insert providing instructions for administering, to a subject in need of ultrasonic therapy, a therapeutically effective amount of at least one dosage form.

50. The article of manufacture of claim 49, wherein the package insert further comprises:

at least one of a table of intensity dose settings in W/cm²;

a table of lesion depth versus signal intensity settings;

a table of degree of tissue injury versus signal intensity settings;

a table of degree of tissue injury versus pulse ratio settings;

a table of size of treatment area versus duration settings;

a table of size of treatment area versus signal Intensity settings; and

a table of size of treatment area versus pulse ratio settings;

or combinations thereof.